ATE336581T1 - Mycoplasma hyopneumoniae antigen mhp3, dafür kodierendes gen und ihre verwendungen - Google Patents

Mycoplasma hyopneumoniae antigen mhp3, dafür kodierendes gen und ihre verwendungen

Info

Publication number
ATE336581T1
ATE336581T1 AT00308421T AT00308421T ATE336581T1 AT E336581 T1 ATE336581 T1 AT E336581T1 AT 00308421 T AT00308421 T AT 00308421T AT 00308421 T AT00308421 T AT 00308421T AT E336581 T1 ATE336581 T1 AT E336581T1
Authority
AT
Austria
Prior art keywords
mhp3
gene coding
mycoplasma hyopneumoniae
hyopneumoniae antigen
antigen
Prior art date
Application number
AT00308421T
Other languages
English (en)
Inventor
Kendall Wayne King
Rebecca Anne Madura
Everett Lee Rosey
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE336581T1 publication Critical patent/ATE336581T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00308421T 1999-09-29 2000-09-26 Mycoplasma hyopneumoniae antigen mhp3, dafür kodierendes gen und ihre verwendungen ATE336581T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15660299P 1999-09-29 1999-09-29

Publications (1)

Publication Number Publication Date
ATE336581T1 true ATE336581T1 (de) 2006-09-15

Family

ID=22560260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00308421T ATE336581T1 (de) 1999-09-29 2000-09-26 Mycoplasma hyopneumoniae antigen mhp3, dafür kodierendes gen und ihre verwendungen

Country Status (12)

Country Link
US (1) US20060233823A1 (de)
EP (1) EP1090995B1 (de)
JP (1) JP2001149085A (de)
CN (1) CN1296953A (de)
AR (1) AR022662A1 (de)
AT (1) ATE336581T1 (de)
AU (1) AU6128900A (de)
BR (1) BR0004488A (de)
CA (1) CA2319213A1 (de)
DE (1) DE60030060T2 (de)
ES (1) ES2267466T3 (de)
NZ (1) NZ507205A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2340455A1 (en) * 2001-03-28 2002-09-28 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
JP2005515162A (ja) * 2001-07-02 2005-05-26 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）を用いた単回ワクチン接種
CN1724686B (zh) * 2004-07-19 2010-06-23 上海复星医学科技发展有限公司 用于检测肺炎支原体的靶序列和试剂盒
KR101773486B1 (ko) * 2013-02-05 2017-08-31 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 항-마이코플라즈마 에스피피. 아단위 백신
DK3072523T3 (en) * 2013-11-21 2019-04-08 Agricultural Tech Res Inst COMPOSITION FOR PREVENTION AND TREATMENT OF INFECTIONS WITH MYCOPLASMA
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用
CN108623663B (zh) * 2018-05-14 2021-09-21 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猪肺炎支原体p97蛋白的免疫原性功能多肽及其编码基因和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242823A (en) * 1986-03-07 1993-09-07 International Genetic Engineering, Inc. Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition

Also Published As

Publication number Publication date
CA2319213A1 (en) 2001-03-29
EP1090995A3 (de) 2001-04-18
ES2267466T3 (es) 2007-03-16
NZ507205A (en) 2002-03-01
DE60030060T2 (de) 2007-02-01
DE60030060D1 (de) 2006-09-28
EP1090995A2 (de) 2001-04-11
CN1296953A (zh) 2001-05-30
US20060233823A1 (en) 2006-10-19
BR0004488A (pt) 2001-11-13
EP1090995B1 (de) 2006-08-16
AR022662A1 (es) 2002-09-04
AU6128900A (en) 2001-04-05
JP2001149085A (ja) 2001-06-05

Similar Documents

Publication Publication Date Title
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
DE60236099D1 (de) Druckverfahren, druckerzeugnisse und drucksteuerung
DE50207849D1 (de) Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
FI20010157L (fi) Probioottiyhdistelmä
DE60224724D1 (de) 3,4-alkylendioxythiophen-verbindungen und ihre polymere
EP1575534A4 (de) D4,5 glycuronidase und ihre verwendungen
DE60234376D1 (de) 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimin-nucleoside und ihre verwendung
ATE380194T1 (de) 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-
DE60235547D1 (de) En daraus, deren herstellung und verwendung
ITTO20030195A1 (it) Condizionatore d'aria.
DE69938555D1 (de) Impfstoff gegen geschlechtlich übertragene krankheiten
ID26611A (id) Turunan-turunan pirol tersubstitusi heteroaril, pembuatannya dan kegunaan-kegunaan terapetiknya
DE60141871D1 (de) Oligonukleotidmarkierungsstoffe und ihre Verwendung
FI20012143L (fi) Itiötön Bacillus subtilis, sen valmistus ja käyttö
DE60030060D1 (de) Mycoplasma hyopneumoniae Antigen MHP3, dafür kodierendes Gen und Ihre Verwendungen
NO20030868D0 (no) N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
DE69925866D1 (de) Aussermembranproteine, ihre gene, und deren verwendung
ITMI20022183A1 (it) Cerniera.
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
DZ3441A1 (fr) Nouvelles phenylpiperazines.
MXPA03004676A (es) Moleculas tipo transportador de casete de union a trifosfato de adenosina y usos de las mismas.
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
DE10045123B8 (de) Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein
BR0103827B1 (pt) cola - pds.
AU2003267162A8 (en) Cancer associated antigens, sga-56m and sga-56mv, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties